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Normal  mouse  spleen  cells  can  be  depleted  of  their  ability to  respond  to 
erythrocyte antigens by treatment with rabbit antiserum against mouse kappa 
light chains and complement (1). This suppression is believed to occur by cytol- 
ysis of cells that bind the antiserum to light chains on their surfaces. This paper 
investigates the cell types and functions in the immune response that might be 
affected by this treatment.  By using  the in vitro response  to  hapten  (2,4,6- 
trinitrophenyl [TNP]) coupled to an erythrocyte antigen (2), one can distinguish 
the roles of hapten-specific precursor cells and carrier-specific "helper" cells (3). 
It was found that the main victim of inactivation by rabbit antiserum against 
mouse  kappa  light  chains  and  complement  is  the  thymus-derived,  carrier- 
specific helper cell. The significance of this with respect to the possibility of the 
presence  of  antibody-like receptors  on  the  surface of  thymus-derived  cells is 
briefly discussed. 
Malerials and Methods 
Cell suspensions were prepared from the spleens of 2-3-month old male and female BDF1 
mice (C57BL/6  9  X DBA/2 o~). They were cultured in a modified Eagle's medium contain- 
ing 5% fetal bovine serum for 3, 4, or 5 days in the presence of erythrocyte antigen (4). The 
immunogen used in culture was either sheep erythrocytes (SRBC) 1 or SRBC coupled with a 
trinitrophenyl hapten,  (TNP-SRBC)  (2). Spleen cells forming  19S antibody against SRBC 
were determined by a modification (4) of the plaque technique of Jerne et al. (5). Spleen cells 
forming  antibody against TNP  were  assayed by plaque formation of horse  erythrocytes 
(HRBC)  coupled with TNP  (TNP-HRBC)  (6). Mice that were primed to SRBC were given 
0.2 m] of a 0.5% suspension of SRBC  (about l0  T  cells) intravenously, 3-7 days before sacrifice. 
Sheep-specific thymus-derived spleen cells were prepared by injection of 2-4 X l0  T  normal 
BDF1 thymus cells and 0.1  ml of 20%  SRBC  (2  X  l0  s cells) intravenously into syngeneic 
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618  Tm~ JOURNAL OF EXPERIMENTAL  MEDICINE  •  VOL.  134, NO. 3, P~. 1, 1971 J.  F.  LESLEY~ J.  R.  KETTMAN,  AND  R.  W.  DUTTON  619 
recipients immediately after irradiation with  1000 R. A  second injection of 0.1  ml of 20% 
SRBC was sometimes give  n at day 4 after irradiation. Spleens were taken from these mice at 
7 or 8 days after irradiation and injection of thymus cells. Bone marrow-derived spleen cells 
were prepared  by injection of 2  X  107 normal BDFI bone marrow cells intravenously into 
syngeneic recipients after 1000 R  irradiation. The spleens of these mice were taken at day 7 
or 8. 
Cells were irradiated in vitro in suspension with 1000 R. A cobalt-60 source was used for 
irradiation of cells and  animals.  Antisera against  mouse kappa light chains were raised in 
rabbits against diethylaminoethyl (DEAE)-cellulose-purified urinary protein from mice bear- 
ing  myeloma tumor  MOPC  46(7).  The  specificities  of the  anti-kappa  sera  were  tested  in 
Ouchterlony plates, where lines of identity were formed against mouse gamma globulin (50% 
[NH412SO4 precipitate of normal mouse serum)  and purified light chains.  Anti-kappa serum 
and complement treatment of spleen cells was as described previously (1). Mouse spleen cells 
were incubated  at  12  )<  l0  T cells/ml with anti-kappa  serum at 0°C for 20 rain.  Guinea pig 
serum  (C  r) was added  as a  complement source and the cells were incubated  for 30 rain at 
37°C. Cells were then washed once and resuspended in fresh medium for culture. The amounts 
used were: 0.5  ml spleen cells,  0.25  ml anti-kappa  serum, 0.25  ml complement.  Guinea pig 
serum used  as a  complement source was  absorbed  when necessary with mouse spleen and 
thymus cells until it was not cytotoxic to mouse cells or to culture responses.  Cell viability 
was tested, after incubating cells at 37°C with the guinea pig serum, by trypan blue dye exclu- 
sion (8). It is important to note that the reaction of mouse spleen cells with anti-kappa serum 
was carried out in the cold. If spleen cells were treated with anti-kappa in the cold and then 
incubated for as little as 15 min at 37°C before the addition of guinea pig serum, the procedure 
no longer inactivated the in vitro response of the spleen cells. 
Some rabbit sera were found to be cytotoxic to mouse thymus cells in the presence of com- 
plement. These sera could be absorbed with thymus cells until they were no longer cytotoxic 
(two or three times at 1 : 20 v/v packed cells to serum)  without significantly affecting the anti- 
kappa  activity (as  determined  by Ouchterlony precipitin lines)  or the effect on spleen cell 
responses. 
RESULTS 
Effect of Anti-Kappa Sera on Cell Populations  Present in the Mouse Spleen.- 
The in vitro response  of mouse  spleen  cells to  erythrocyte  antigens  can  be ir- 
reversibly abolished by a  pulse pretreatment  of the cells with rabbit  antiserum 
against  mouse  kappa  light  chains  (anti-kappa  serum)  and  complement.  This 
inhibition  can  be  prevented  by  preincubation  of  the  anti-kappa  serum  with 
normal mouse  serum  (1),  with partially  purified mouse gamma  globulin  (50% 
[NH412SO4  precipitate),  or  with  purified  kappa  chains  from  myeloma  urinary 
protein  (Table I). Inhibition  of the immune response is believed to be a  conse- 
quence of the cytolysis  of cells which  specifically bind  anti-kappa  antibody  to 
membrane-associated  light  chains  on  their  surface.  Subsequent  experiments 
sought to investigate the cell functions that were eliminated after treatment  of 
a  spleen  cell population  with anti-kappa  serum  and complement.  The in vitro 
hapten-carrier  system,  consisting  of  trinitrophenyl  groups  coupled  on  sheep 
erythrocytes  (TNP-SRBC)  (3),  was  used  to  distinguish  thymus-derived,  car- 
rier-specific helper cell activity and  bone marrow-derived  hapten-specific  anti- 
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In this system, riormal spleen cell cultures, in the presence of TNP-SRBC  as 
immunogen,  show a  greatly enhanced  primary response  to  TNP  if irradiated 
spleen  cells from mice that  have been immunized  to  SRBC  are added  (3  and 
Fig. 1). All anti-TNP plaque-forming cells (PFC) still come from normal spleen, 
since the primed irradiated population can generate no antibody-forming cells. 
Control cultures of irradiated primed cells give no PFC against TNP  (last line 
TABLE  I 
Specificity of Inhibition of Normal Spleen Culture Responses by Treatment ~f Cells with Rabbit 
Anti-Mouse Kappa Serum and Complemevl 
Spleen cell treatment  __  Plaque forming cells/culture 
Experiment A  Anti-TNP  Anti-SRBC 
None  554  2176 
C' only  935  1860 
anti-k q- C'  18  0 
anti-k (0.1 ml)  +  MGG (about 3 nag) -]- C'  849  2610 
Experiment B 
None 
C' only 
anti-k (0.1 ml) q- C' 
anti& (0.1 ml) +  P4 (0.11 rag)  +  C' 
anti& (0.1 nal)+ P4 (0.31 rag) +  C' 
anti& (0.1 ml) +  P4*  (0.10 rag) +  C' 
anti-k (0.1 ml)  q- P4*  (0.25 rag)  +  C' 
683 
939 
0 
2062 
450 
93 
608 
Anti-kappa serum was raised in rabbits against the purified kappa chain  designated P4 
(MOPC  46).  Antiserum was neutralized, where  indicated, by preincubation for 15 rain at 
room temperature with partially purified  mouse gamma globulin (MGG)  (50% [NH4]2SO4- 
precipitated normal mouse serum)  (Exp. A), or with DEAE-cellulose  column-purified kappa 
chains (174). All cultures contained 12  X  106 spleen cells initially; 3  X  108 TNP-SRBC in 
Exp.  A, or 3  X  107 SRBC in Exp. B were added at time 0.  Responses  are PFC/culture at 
day 4. 
* A different  light chain preparation than was used to immunize the rabbits. 
of Table II, and III). The irradiated population is providing an excess of car- 
rier-specific helper cells which enable stimulation of more anti-TNP precursors 
in  the normal spleen population  than  is possible by the  normal  spleen's own 
SRB C-specific helper cells. The antigen specificity of preimmunization to carrier 
has been demonstrated (3). 
There is increasing evidence that carrier-specific helper activity is a  function 
of the thymus-derived cell population in the spleen. In an in vivo cell transfer 
system,  Raft  (9)  has  shown  that  the  helper activity of carrier-primed spleen 
cells in an anti-hapten response is abolished bv treatment of the carrier primed J.  F.  LESLEY~  J.  R.  KETTMAN,  AND  R.  W.  DUTTON  621 
population with  antiserum  against  the mouse thymus cell antigen,  theta,  and 
complement. The hapten-primed precursor population is not affected by anti-0 
treatment.  Similar  results  have  been  obtained  with  the  in  vitro  response  to 
TNP erythrocytes (10). Anti-8 treatment of the carrier  (erythrocyte)  immune 
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FIG.  1. Anti-kappa  inhibition  of irradiated  primed  spleen cell enhancement  of normal 
spleen anti-TNP response. A total of 1.0 ml of ce]ls at 12 X  106 cells/ml were cultured with 
TNP-SRBC. SRBC-primed spleen cells were from mice injected 3 days earlier with 0.2 ml of 
0.5% SRBC. They were irradiated  in vitro with 1000 R. Anti-kappa  treatment of the irradi- 
ated, primed cells was as described in the text. Data from Fig. 3 of reference 10. 
irradiated  population abolishes its ability to enhance the anti-hapten response 
of normal spleen cultures. 
The irradiated,  SRBC-immune population was treated with anti-kappa and 
complement to determine the effect on the carrier-specific helper activity. The 
helper activity of the irradiated primed population can be completely abolished 
by a  pulse  treatment  with  anti-kappa  serum  and  complement before mixing 
them with normal spleen  (Fig.  1 and Table II). The fact that there is no in- 622  SURFACE  1MMUNOGLOBULINS  OF  THYMUS-DERIVED  CELLS 
hibition of  the normal spleen cell response argues against carry-over of  anti- 
kappa  antibody  or  nonspecific cytotoxic  effects  after  anti-kappa  treatment 
which might continue after the populations are mixed. The specificity of elimi- 
nation of  the  carrier  effect  by anti-kappa serum was  verified by  the  use  of 
purified kappa light chains to block anti-kappa antibody. This prevented anti- 
kappa inhibition of the helper activity (Table II). Precipitating antigen-anti- 
body  complexes  (mouse  kappa  chains,  rabbit  anti-kappa  antibody)  were 
TABLE  II 
Blocking Anti-Kappa  Inhibition of Carrier Enhancement with Purified Light Chains 
Anti-TNP responses  (PFC/calture) 
Day 3  Day 4  Day 5 
Normal spleen  318  382  1489 
Normal spleen +  irradiated SRBC-primed  1552  4425  12,679 
Normal spleen +  anti-k-treated irradiated  384  537  2498 
SRBC-primed spleen 
Normal spleen +  P4-blocked  anti-k-treated  Jr-  1328  2664  13,420 
radiated SRBC-primed spleen 
Normal spleen _c P4-blocked anti-K- and ALS-  --  --  2145 
treated  irradiated  SRBC- 
primed spleen 
SRBC-primed spleen  2899  9413  29,972 
Irradiated SRBC-primed spleen  2  0  0 
1 ml of rabbit anti-mouse kappa serum was incubated with 0.4 mg purified light chain 
designated P4, to which the anti-serum was raised, overnight at 4°C. The precipitating  ma- 
terial was sedimented and the neutralized serum was used to treat cells in the presence of 
complement. Irradiated,  SRBC-primed cells were spleen cells from mice injected with 0.2 ml 
of 0.5% SRBC (about 107 cells) 3 days before sacrifice. Primed cells were irradiated  in sus- 
pension with 1000 R and 6 X  106 were added/culture  to normal spleen cells. Normal spleen 
cells, 6 X  l0  s cells/culture, were untreated.  A rabbit anti-mouse lymphocyte serum (ALS) 
was also used, in the presence of P4-blocked anti-kappa h- C', to treat irradiated,  SRBC- 
primed cells as verification of the availability  of C' for lysis. 3 X 10  6  TNP-SRBC were added 
at time 0. Values given are PFC  recovered/culture on days 3, 4, and 5. 
removed by centrifugation from the mixture of anti-kappa and kappa chains 
before the serum was added to cells with complement. In line 5  of Table II, 
rabbit  anti-mouse lymphocyte serum was  added  along with  the  neutralized 
anti-kappa serum to verify that any antigen-antibody complexes remaining in 
the serum are not able to fix enough complement to prevent lysis when another 
antibody against mouse lymphocytes is present. 
The effect of  anti-kappa and complement treatment on precursors to anti- 
body-forming cells supplied by the normal spleen was examined. It was found 
that normal spleen cells, rendered incapable of response to TNP or to SRBC by 
treatment with  anti-kappa serum and complement could be  restored  by the j.  F.  LESLEY, J.  R.  KETTMAN, AND  R.  W.  DUTTON  623 
addition of irradiated primed cells (Table III). The anti-kappa-treated spleen 
must be supplying the precursors of the anti-TNP and anfi-SRBC plaque-form- 
ing  cells  since  the  irradiated  spleen  cannot  generate  antibody-forming  cells. 
Sometimes the restoration by irradiated primed cells can reach helper cell-en- 
hanced levels of untreated cells, indicating that little damage has been done to 
the precursor population of  the normal spleen by treatment  with  anti-kappa 
serum and complement. The variability in inhibition and restoration shown in 
this experiment (especially the last column, Table III) is representative of the 
variability seen  among  several experiments  of  this design. Irradiated normal 
TABLE III 
Restoration of Responses of A nti-Kappa-Treated Normal Spleen Cells by Irradiated, 
SRBC-Immune Spleen Cells 
Normal spleen  treatment 
anti-TNP response  anti-SRBC iesponse 
(PFC/culture)  (PFC/culture) 
Normal  Normal  spleen  Normal  Normal  spleen 
spleen  q- irradiated  spleen  q- irradiated 
alone  SRBC-primed  alone  SRBC-primed 
None  334  3727  2363  4131 
anti-k+C'  0  1220  2  180 
2  2550  28  650 
anti-k*+C'  3  2469  38  2550 
12  2380  245  2200 
Irradiated SRBC-primed  0  --  59 
6 X  106 normal, unirradiated, spleen cells were present in all cases. 6 X  l0  G  SRBC-primed 
irradiated spleen cells were added where indicated. Primed cells were obtained from the spleens 
of mice injected with 0.2 ml of 0.5% SRBC  (about 107 cells) 3 days before culture. They were 
irradiated with 1000 R before culturing. 3 X  106 TNP-SRBC were added at time 0. Values 
given are PFC recovered/culture on day 4. 
*  Anti-kappa serum was used here at ~  the concentration normally used. 
BDF1  spleen cells do not restore anti-kappa-treated normal  BDF1 cells, indi- 
cating that immunization to the carrier of TNP  is required. 
Effect of Anti-Kappa Serum on Cell  Populations  Derived from the Thymus.-- 
Mitchell and Miller (11) demonstrated the antigen requirement for preparation 
of thymus-derived cells in bone marrow-thymus cell interactions in irradiated, 
reconstituted  mice  responding  to  erythrocyte  antigens.  Vann  and  Kettman  2 
(and  see ref.  10)  have found  that  carrier-primed thymus-derived spleen  cells 
(from mice irradiated and injected with 3  X  107 thymus cells and SRBC 7 days 
before sacrifice) can substitute for irradiated SRBC immune spleen cells in the 
enhancement of the in vitro anti-TNP response of normal spleen cells cultured 
Vann, D. C., and J. Kettman. In vitro cooperation of cells of bone marrow  and thymus 
origins in the production of antibodies. Manuscript in preparation. 624  SURFACE  IMMUNOGLOBULINS  OF  THYMUS-DERIVED  CELLS 
in the presence of TNP-SRBC.  Such a  thynms-derived spleen population con- 
tains no precursors to antibody-forming cells and can make no immune response 
by itself. Its helper activity is not affected by irradiation.  ~ Table IV shows the 
helper activity of SRBC-immune  thymus-derived spleen cells in  combination 
with normal spleen cells. The helper activity is eliminated by treatment of this 
population  with  anti-kappa  serum  and  complement.  Anti-kappa-depleted 
normal  spleen  can  also  be  restored  by  SRBC-primed  thymus-derived  spleen 
cells. 
TABLE IV 
Enhancement of TNP Responses with Carrier-Primed Thymus-Derived Cells. Anti-Kappa plus 
Complement Sensitivity of Carrier-Primed Thymus-Derived Cells 
Anti-TNP  Spleen cells in culture  PFC/culture 
Normal spleen  199 
Normal spleen  +  Thymus-derived spleen (SRBC-primed)  2896 
Normal spleen  +  anti&  +  C'-treated  thymus-derived  spleen  105 
(SRBC-primed) 
Anti-k +  C'-treated normal spleen  30 
Anti-k +  C'-treated +  Thymus-derived spleen  (SRBC-primed)  840 
normal spleen 
Anti-k +  C'-treated  +  anti&  +  C'-treated  thymus-derived  spleen  5 
normal spleen  (SRBC-primed) 
Thymus-derived spleen (SRBC-primed)  0 
6  X  l0  s normal spleen  cells or  anti-kappa +  complement-treated normal spleen  cells 
were  cultured with or without  6  X  106  thymus-derived cells primed to  SRBC.  Thymus- 
derived cells were spleen cells from mice lethally irradiated (1000 R) and injected with 3  X 
107 normal thymus cells and 0.1 ml of 20% SRBC  (about 2 X 108 cells) 7 days before culture. 
Where indicated, thymus-derived, SRBC-primed cells were  treated with anti-kappa serum 
and complement.  3  X  106 TNP-SRBC were added at time 0. Values given are anti-TNP 
PFC recovered/culture on day 5. 
t~ect of Anti-Kappa Serum on Cell Populations Derived from the Bone Mar- 
row.--Bone marrow-derived spleen cells can be prepared by injection of 2  X  107 
normal bone marrow cells into lethally irradiated hosts 7 days before sacrifice. 
There is no antigen requirement in the preparation of these cells. Bone marrow- 
derived cells can be stimulated to generate anti-SRBC and anti-TNP responses 
in vitro if they are cultured with SRBC-educated thymus-derived cells or with 
irradiated SRBC-irnmune spleen cells (9). These cells were used to test further 
for anti-kappa sensitivity of precursors. Bone marrow-derived cells were treated 
with  rabbit  anti-mouse kappa  serum  and  complement  in  the  same way  that 
normal spleen, irradiated primed spleen, and primed thymus-derived cells were 
treated previously. When  treated  and  untreated  bone  marrow-derived spleen 
cells were  cultured  with irradiated, SRBC-immune  spleen cells as a  source  of ~.  F.  LESLE¥,  J.  R.  KETTMAN,  AND  R.  W.  DUTTON  625 
helper cells, no depression in the response to TNP or to SRBC could be shown 
as a  result of anti-kappa treatment (Table V).  Thus, under conditions where 
thymus-derived spleen cells are sensitive to anti-kappa serum and  complement, 
precursors are not sensitive. It is not known  whether higher concentrations of 
antisera would have been inhibitory. It was noted that better restorations of the 
response of anti-SRBC  precursors by irradiated primed  cells  were seen  after 
treatment with a  slightly lower anti-kappa concentration (last  column,  Table 
III). 
TABLE  V 
Anti-TNP and Anti-SRBC Responses  of Anti-Kappa-Treated  and  Untreated Bone Marrow- 
Derived Spleen  Cells Diluted  in Irradiated,  SRBC-Primed Spleen  Cells 
Anti-TNP PFC/106 cells  Anti-SRBCPFC/106  cells 
Treatment of BM-derived spleen cells  None  Anti-k +  C'  None  Anti-k +  C' 
(Cells cultured) 
Irradiated  SRBC-primed spleen  5  --  401  -- 
BM-derived spleen  7  0  2  6 
BM-derived +  Irradiated  SRBC- 
Spleen  Primed spleen 
0.7 ml  0.3 ml  5  0  2035  1437 
0.5 ml  0.5 ml  63  123  4393  6710 
0.3 ml  0.7 ml  34  211  6686  5922 
A  total  of  1 ml of cells at  12  N  10  e cells/ml were cultured with TNP-SRBC, Irradiated 
primed spleen cells were from mice injected  3  days earlier with 0.2  ml of 0.5%  SRBC  and 
irradiated with 1000 R. Bone marrow  (BM)-derived cells were spleen cells from mice lethally 
irradiated  (1000 R)  and injected with 2  >(  107 normal syngeneic bone marrow cells 7  days 
before culture.  BM-derived  spleen cells were  treated  with anti-mouse kappa  serum by the 
same procedure  used to  treat  normal,  irradiated' primed,  and  thymus-derived spleen ceils. 
Anti-kappa +  C' treatment of normal spleens in concurrent experiments reduced responses 
by at least  100-fold. 3  N  l0 B  TNP-SRBC were given at  time 0.  Values given are PFC/106 
cells recovered on day 4. 
DISCUSSION 
It is clear that, in this system, the thymus-derived helper cells are rendered 
inactive, and are presumably lysed, by antiserum against mouse kappa chains 
and complement, and  that  the precursors to antibody-forming cells are rela- 
tively unaffected. Specific attempts to demonstrate inactivation of precursors 
with anti-kappa serum and complement in bone marrow-derived spleen popu- 
lations were unsuccessful (see Table V). There may be some indication of dam- 
age to precursors in the failure in some cases (e.g. higher anti-kappa concentra- 
tions, as shown in Table III) to obtain complete restoration of anti-kappa and 
complement-treated normal spleen with carrier-primed helper cells (irradiated 
primed cells or carrier-educated thymus-derived cells). However, the data es- 626  SURFACE  IMMUNOGLOBULINS OF  THYMUS-DERIVED  CELLS 
tablish clearly different sensitivitie3 of helper cell and precursor cell activity to 
anti-kappa serum and complement. (It is also of interest that mature plaque- 
forming cells are not sensitive to lysis by anti-kappa serum and complement, 
although the formation of IgM plaques  can be inhibited by the presence  of 
anti-kappa serum in the plaque assay. Since mature antibody-forming cells can 
be lysed by antisera against H-2 specificities,  it must be concluded that these 
cells have sites for complement and membranes sensitive to lysis by antibody 
and complement.) 
The results of treatment of spleen cells with rabbit anti-mouse kappa chain 
serum and complement before culture resemble those obtained upon treatment 
of mouse spleen cells with homologous antisera against the mouse thymus cell 
antigen 8 (9 and 10). We take these experiments as strong evidence for the pres- 
ence  of immunoglobulin-like molecules, consisting at least of light chains of 
the kappa class,  on the surfaces of thymus-derived cells. Since thymus-derived 
populations which are involved in cell  cooperation in thymus-dependent hu- 
moral responses are antigen specific (11),  it would be reasonable to postulate 
that the cell surface light chains detected here are involved in antigen recogni- 
tion by helper cells. 
There  is  other  evidence  suggestive  of  immunoglobulin-like receptors  on 
thymus-derived lymphocytes. Greaves, Torrigiani, and Roitt (12) were able to 
inhibit delayed hypersensitivity and homograft reactions in cultures of human 
lymphocytes with antisera against human light chains. Mason and Warner (13) 
found inhibition of delayed hypersensitivity and graft-versus-host  reactions in 
irradiated mice reconstituted with lymphocytes that had been preincubated in 
antisera against mouse light chains.  They found no inhibition with antisera 
against mouse heavy chain classes. These primarily cellular immune responses 
are thought to be functions of thymus-derived lymphocytes. Inhibition of these 
responses by anti-light chain antibody is believed to occur by blocking of anti- 
gen-specific  cell  surface immunoglobulin-like receptors.  Humoral immune re- 
sponses can also be inhibited by the presence of antisera against mouse immuno- 
globulins in vitro (1 and 14) and in vivo (15), but here it is not clear what cell 
type is being blocked by the antisera,  and antisera against other  than light 
chain immunoglobulin components are effective. Greaves, Mtiller, and M611er 
(16) have found evidence for light chains on anti-0-serum sensitive-, and there- 
fore  presumably  thymus-derived,  mouse  rosette-forming lymphocytes, since 
the binding of sheep red blood cell  antigen to these cells is inhibited by anti- 
mouse light chain sera, but not by anti-heavy chain sera. 
Contrary to these indications of immunoglobulin components on the surface 
of thymus-derived cells is Raft's finding (17) that cells staining with fluorescent 
anti-mouse  inlmunoglobulin antibodies  are  a  distinct  population  from  cells 
stained by anti-0-serum. Since the anti-0-staining population cannot be labeled 
independently, a certain amount of overlap might not be discernible. Alterna- j.  ~'.  LESLE¥, J.  R.  KETTMAN, AND R.  W.  DUTTON  627 
tively, immunoglobulin may be only acquired by thymus-derived cells as theta 
is diminished  during  maturation  after leaving the thymus,  in which  case the 
sensitivity of the fluorescent technique may not be adequate  to detect  small 
amounts of immunoglobulin on theta-staining cells,  or small amounts of theta 
on heavily immunoglobulin-staining cells. 
It is perhaps interesting to note that in our hands the sensitivity to comple- 
ment is lost when anti-kappa-treated cells are incubated in  the warm for 15 
rain in the absence of free anti-kappa. The mechanism of this effect is not clear, 
but it does not seem to be due to dissociation of the antigen-antibody complexes 
on the cell surface. It is possible that minor differences in technique can account 
for conflicting observations. 
If  thymus-derived  cells  which  have immunoglobulin  components  on  their 
surfaces can be lysed by anti-mouse kappa sera, why are precursors to antibody- 
forming cells, which we also believe to possess antigen-sensitive, immunoglobu- 
lin-like receptors, not also inactivated by antisera against mouse immunoglobu- 
lin  components?  It  is  possible  that  membrane-bound  immunoglobulin  is 
associated with cell membranes in different ways in different cell types and at 
various stages of maturation. Precursor cell immunoglobulin could be attached 
or be distributed in such a way that the cells are not vulnerable to complement- 
mediated lysis. The invulnerability of precursor cell function,  however, is not 
evidence that precursors do not have membrane-associated immunoglobulin re- 
ceptors for antigen. In preliminary studies to be reported shortly, we have found 
that anti-kappa serum prevents the induction  of an unresponsive state which 
occurs when bone marrow-derived cells are incubated with polyvalent hapten 
on a nonimmunogenic carrier.  3 The vulnerability of thymus-derived cell helper 
function is evidence for the existence of immunoglobulin molecules on the sur- 
faces of these cells. 
SUMMARY 
Preculture  treatment  of normal spleen  cells with  antiserum  against  mouse 
kappa light chains and complement was found to inhibit in vitro responses of 
these cells to TNP and erythrocyte (carrier) antigens, primarily by elimination 
of a thymus-derived helper component required for the response. Spleen popu- 
lations inactivated in this way could be reconstituted with irradiated,  carrier- 
immune spleen cells or with carrier-educated thymus-derived spleen cells.  The 
ability  of  helper  populations  (i.e.  irradiated,  carrier-immune  spleen  cells  or 
carrier-educated thymus-derived spleen cells)  to enhance the response of normal 
spleen cells to hapten was eliminated by pretreatment of the helper cells with 
anti-kappa  serum  and  complement.  No  significant  effect  of  anti-kappa  and 
3  Kettman,  J., and J. Lesley. Induction in vitro  of specific unresponsiveness against the 
2,4,6-trinitrophenyl  determinant.  II. Prevention  and  reversal of the  unresponsive state. 
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complement treatment on precursor cell populations in normal spleen or bone- 
marrow-derived  spleen  could  be  demonstrated.  The  data  are  interpreted  as 
evidence for the presence of immunoglobulin components. The function of these 
molecules is not established but it would be reasonable to assume that they are 
involved in antigen recognition, on the surface of thymus-derived cells. 
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